Organization
University of Genova, Genova, Italy
7 abstracts
Abstract
Characterization of the immune microenvironment in matched primary and metastatic breast cancer lesions from the AURORA study: BIG 14-01.Org: Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Academic Trials Promoting Team (ATPT), Brussels, Belgium, Fundación Instituto Valenciano de Oncología (FIVO), GEICAM Spanish Breast Cancer Group, Valencia, Spain, Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium, Department of Mathematics, Università degli Studi di Genova, San Martino, Italy,
Abstract
Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative.Org: Université Libre de Bruxelles (ULB), Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium, Breast International Group, Brussels, Belgium, Dana-Farber Cancer Institute, Vall d’Hebron Institute of Oncology (VHIO),
Abstract
Impact of young age at diagnosis on survival outcomes in patients with early breast cancer according to tumor subtype: Pooled analysis of 5 randomized clinical trials from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM).Org: Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy, Genoa, IT, Italy, Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Istituto Nazionale Tumori Napoli IRCCS "Fondazione Pascale", Napoli, Italy, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy, Department of Medicine (DAME), University of Udine; Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Udine, Italy, Precision Medicine Unit in Senology Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, IRCCS Sacro Cuore Don Calabria, Negrar Di Valpolicella, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy and Academic Trials Promoting Team, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium, IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy, Medical Research Council at UCL, London, United Kingdom, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova and Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino Genoa, Genova, Italy, University of Genova, Genova, Italy, IRCCS Ospedale Policlinico San Martino, Istituto Nazionale Tumori Napoli IRCCS Fondazione Pascale, Napoli, Italy, University Federico II,
Abstract
Early tumor shrinkage (ETS) as clinical factor to select maintenance with cetuximab (cet) monotherapy in RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts): A secondary endpoint analysis of the ERMES study.Org: Fondazione Policlinico Universitario A. Gemelli-IRCCS-UOC Oncologia Medica, Rome, Italy, Medical Oncology Unit, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy, Unit of Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, National Cancer Institute of Naples, G.Pascale Foudation, Brusciano, Italy, Oncology Unit, Foundation IRCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy,
Abstract
Blood eosinophils as prognostic biomarkers for advanced urothelial carcinoma in patients treated with avelumab: First results of the MALVA study (Meet-URO 25).Org: Clinical Oncology Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, Careggi University Hospital, Florence, Italy, Istituto Oncologico Veneto, IOV-RCCS, Padova, Italy, Ospedale A.R.N.A.S Civico,
Abstract
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS Org: Department of Medicine, University of Padova, Padova, La Sapienza University of Rome, Rome, University of Pavia, Pavia, Italy, University of Pisa, Pisa, Italy, University of Bari, Bari,
Abstract
APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (52-WEEK) IMPROVEMENT IN MEASURES OF DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM 3 PHASE 3, RANDOMIZED, CONTROLLED TRIALS Org: University of California San Diego, San Diego, United States, University of Genova, Genova, Italy, Swedish Medical Center and University of Washington School of Medicine, Seattle, United States, Toronto Western Hospital, Toronto, Canada, University of Sheffield, Sheffield, United Kingdom,